SlidesetHIVAbstract: Prevalence of neuropsychiatric conditions among HIV positive compared to HIV negative commercially insured individuals in 2017 NAFLD with dyslipidemia (#5) | Joshua Cohen, PhDView Slideset
SlidesetHIVAbstract: Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in a rapid initiation model of care for HIV-1 infection: Week 24 interim analysis of the DIAMOND study (#6) | Keith Dunn, PharmD, BCPS, AAHIVEView Slideset
SlidesetHIVAbstract: Initial viral load decline and response rates by baseline viral load strata with dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: Pooled results from the GEMINI studies (#7) | Michael AboudView Slideset
SlidesetHIVHispanic/Latino longitudinal cohort of HIV-seropositive women and neurological complications | Loyda Melendez, PhDView Slideset
SlidesetHIVAbstract: Rhesus macaque model of SIV/SHIV-Zika co-infection (#9) | Siddappa ByrareddyView Slideset
SlidesetRSVDevelopment of protease inhibitors against norovirus and other emerging viruses | Ladislau KovariView Slideset
SlidesetPresentation of Gertrude Elion Distinguished Lecturer Award recipient | Rowena Johnston, PhDView Slideset
SlidesetOpening remarks and presentation of Gertrude Elion Distinguished Lecturer Award | Raymond Schinazi, PhD, DScView Slideset
SlidesetHIVState of the Art Lecture: Molecular basis for HIV latency | Jonathan Karn, PhDView Slideset
SlidesetHIVTuberculosisGertrude Elion Distinguished Lecturer Award Lecture: Innovation with an Impact: Development of HIV and TB drugs | Paul Stoffels, MDView Slideset
SlidesetHIVHIV reservoir dynamics: Implications for HIV latency establishment and reversal | Deanna Kulpa, PhDView Slideset
SlidesetHIVBaricitinib reverses HIV associated neurocognitive disorders and reservoir seeding in a SCID mouse model | Christina Gavegnano, PhDView Slideset
SlidesetHIVState of the Art Lecture: Harnessing the immune system to eliminate and/or control HIV | Steven Deeks, MDView Slideset
SlidesetHIVPotential for HIV cure by stem cell transplantation (IciStem) | Monique Nijhuis, PhDView Slideset
SlidesetHIVAbstract: Differential detection of M184V/I between plasma historical HIV genotypes and proviral DNA from PBMCs (#3) | Nicolas MargotView Slideset
SlidesetHIVAbstract: Oral ABX464 has a dose dependent reduction in the HIV-1 DNA reservoir in CD4+ Peripheral Blood T Cells (#2) | Jean-Marc SteensView Slideset
SlidesetPresentation of Barry-Wainberg DART Achievement Award and recipient | Charles Boucher, MD, PhDView Slideset
SlidesetState of the Art Lecture: Rational design of doravirine (DOR): From bench to patients | Daria Hazuda, PhDView Slideset
SlidesetA post-transcriptional feedback mechanism for noise suppression and fate stabilization | Leor Weinberger, PhDView Slideset
SlidesetHIVBarry-Wainberg DART Achievement Award Lecture: Overview of the research conducted at the Irsicaixa Foundation | Bonaventura Clotet, MD, PhDView Slideset
